Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Curis Inc

CRIS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of CRIS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
CRIS Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
CRIS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CRIS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in CRIS holdings by institutional investors

Quarterly net insider trading by CRIS's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $15,000 Jan 18, 2018 Issue: Economics/Economic Development
  • $10,000 Jul 16, 2017 Issue: Economics/Economic Development
  • $10,000 Apr 18, 2017 Issue: Economics/Economic Development
  • $10,000 Jan 19, 2017 Issue: Economics/Economic Development
  • $10,000 Oct 16, 2016 Issue: Economics/Economic Development
  • $10,000 Jul 17, 2016 Issue: Economics/Economic Development
  • $10,000 Apr 19, 2016 Issue: Economics/Economic Development
  • $10,000 Jan 17, 2016 Issue: Economics/Economic Development
  • $10,000 Oct 18, 2015 Issue: Economics/Economic Development
  • $10,000 Apr 19, 2015 Issue: Economics/Economic Development
  • $10,000 Jan 19, 2015 Issue: Economics/Economic Development
  • $10,000 Oct 11, 2014 Issue: Indian/Native American Affairs

Former government officials who have lobbied for CRIS

Quiver Logo

No former government officials on record as having lobbied for CRIS

Revolving Door Dashboard

CRIS Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

CRIS Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
CRIS Income Statement
CRIS Balance Sheet
CRIS Cash Flow
U.S. Patents

New CRIS patent grants

  • Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Aug. 08, 2017
  • Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety May. 23, 2017
  • Patent Title: Fused amino pyridine as hsp90 inhibitors Apr. 25, 2017
  • Patent Title: Fused amino pyridine as hsp90 inhibitors Aug. 02, 2016
  • Patent Title: Pyridyl inhibitors of hedgehog signalling Apr. 26, 2016
  • Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Feb. 02, 2016
  • Patent Title: Mediators of hedgehog signaling pathways, compositions and uses related thereto Nov. 03, 2015
  • Patent Title: Tyrosine kinase inhibitors containing a zinc binding moiety Oct. 27, 2015
  • Patent Title: Crystalline forms of fused amino pyridines as hsp90 inhibitors Oct. 06, 2015
  • Patent Title: Quinazoline based egfr inhibitors Aug. 18, 2015
  • Patent Title: Fused amino pyridine as hsp90 inhibitors May. 26, 2015
  • Patent Title: Quinazoline based egfr inhibitors containing a zinc binding moiety May. 05, 2015
  • Patent Title: Quinazoline based egfr inhibitors containing a zinc binding moiety Mar. 10, 2015
  • Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Dec. 09, 2014
  • Patent Title: Small organic molecule regulators of cell proliferation Oct. 07, 2014
  • Patent Title: Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety Sep. 30, 2014
  • Patent Title: Mediators of hedgehog signaling pathways, compositions and uses related hereto Aug. 26, 2014
  • Patent Title: Rna interference modulators of hedgehog signaling and uses thereof Aug. 12, 2014
  • Patent Title: Mediators of hedgehog signaling pathways, compositions and uses related thereto Jul. 08, 2014
  • Patent Title: Fused amino pyridines for the treatment of brain tumors May. 13, 2014
  • Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Apr. 29, 2014
  • Patent Title: Cdk inhibitors Apr. 08, 2014
  • Patent Title: Variant hhip1 protein and methods and uses thereof Jan. 07, 2014
  • Patent Title: Quinazoline based egfr inhibitors containing a zinc binding moiety Dec. 10, 2013
  • Patent Title: Fused amino pyridine as hsp90 inhibitors Nov. 19, 2013
  • Patent Title: Cdk inhibitors containing a zinc binding moiety Oct. 22, 2013
  • Patent Title: Formulation of quinazoline based egfr inhibitors containing a zinc binding moiety Aug. 27, 2013
  • Patent Title: Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling Jul. 16, 2013
  • Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Jun. 11, 2013
  • Patent Title: Quinazoline based egfr inhibitors containing a zinc binding moiety Jun. 04, 2013
  • Patent Title: Tyrosine kinase inhibitors containing a zinc binding moiety Apr. 23, 2013
  • Patent Title: Functional antagonists of hedgehog activity Apr. 02, 2013
  • Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Feb. 05, 2013
  • Patent Title: Methods of treating pancreatic or liver cancer using hedgehog antagonists Jan. 22, 2013
  • Patent Title: Mediators of hedgehog signaling pathways, compositions and uses related thereto Jan. 15, 2013
  • Patent Title: Quinazoline based egfr inhibitors Jan. 08, 2013
  • Patent Title: Fused amino pyridine as hsp90 inhibitors Dec. 04, 2012
  • Patent Title: Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety Sep. 25, 2012
  • Patent Title: Small organic molecule regulators of cell proliferation Sep. 25, 2012
  • Patent Title: Quinoxaline inhibitors of the hedgehog signalling Sep. 25, 2012
  • Patent Title: Mediators of hedgehog signaling pathways, compositions and uses related thereto May. 01, 2012
  • Patent Title: Methods and compositions for regulating lymphocyte activity May. 01, 2012
  • Patent Title: Small organic molecule regulators of cell proliferation Mar. 06, 2012
  • Patent Title: Formulation of quinazoline based egfr inhibitors containing a zinc binding moiety Feb. 21, 2012
  • Patent Title: Quinazoline based egfr inhibitors Jul. 12, 2011
  • Patent Title: Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety Apr. 19, 2011
  • Patent Title: Pyridyl inhibitors of hedgehog signalling Feb. 15, 2011
  • Patent Title: Tyrosine kinase inhibitors containing a zinc binding moiety Feb. 15, 2011
  • Patent Title: Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety Dec. 07, 2010
  • Patent Title: Mediators of hedgehog signaling pathways, compositions and uses related thereto Oct. 19, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to CRIS from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
CRIS News

Recent insights relating to CRIS

CNBC Recommendations

Recent picks made for CRIS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CRIS

CRIS Analyst Ratings

CRIS Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
CRIS Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $CRIS stock a Buy, Sell, or Hold?

  • What is the price target for $CRIS stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

CRIS Top Shareholders
Shareholder
Shares Held
CRIS Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $CRIS stock?

  • Who owns the most shares of $CRIS stock?

  • What funds own $CRIS stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CRIS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CRIS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About CRIS

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

  • Address Lexington, MA
  • Market Cap 2.0 million
  • Employees 24
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Curis Inc (CRIS) Historical Stock Prices

Curis Inc (CRIS) closed at $0.8299 on September 25, 2026. Over the past year its adjusted close ranged from $0.8299 to $33.80. Daily prices go back to January 2, 2014, 3,202 trading days in all.

  • 1 month-46.11%
  • 3 months-87.07%
  • Year to date-95.80%
  • 1 year-97.47%
  • 3 years-99.51%
  • 5 years-99.97%
  • Max-99.99%
See every congressional and insider trade on the CRIS price chart

Quiver Premium charts CRIS's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 25, 2026 0.8977 0.9598 0.8096 0.8299 0.8299 290,534
Sep 24, 2026 0.9658 0.9890 0.8600 0.8793 0.8793 309,197
Sep 23, 2026 1.00 1.01 0.9408 0.9519 0.9519 144,152
Sep 22, 2026 0.9750 1.07 0.9656 1.00 1.00 165,144
Sep 21, 2026 1.04 1.07 0.9500 0.9746 0.9746 184,331
Sep 18, 2026 1.11 1.13 1.00 1.00 1.00 123,058
Sep 17, 2026 1.12 1.18 1.07 1.09 1.09 139,401
Sep 16, 2026 1.08 1.15 1.07 1.12 1.12 180,395
Sep 15, 2026 1.12 1.21 1.08 1.13 1.13 156,753
Sep 14, 2026 1.16 1.19 1.11 1.12 1.12 136,019
Sep 11, 2026 1.18 1.25 1.13 1.13 1.13 131,297
Sep 10, 2026 1.21 1.24 1.11 1.16 1.16 146,654
Sep 9, 2026 1.34 1.34 1.18 1.20 1.20 188,411
Sep 8, 2026 1.32 1.35 1.26 1.27 1.27 144,678
Sep 4, 2026 1.37 1.39 1.30 1.35 1.35 96,907
Sep 3, 2026 1.42 1.42 1.35 1.37 1.37 126,042
Sep 2, 2026 1.46 1.48 1.38 1.38 1.38 85,272
Sep 1, 2026 1.45 1.47 1.40 1.42 1.42 65,423
Aug 31, 2026 1.48 1.53 1.41 1.49 1.49 35,842
Aug 28, 2026 1.51 1.58 1.45 1.49 1.49 119,833
Aug 27, 2026 1.56 1.59 1.40 1.50 1.50 288,289
Aug 26, 2026 1.59 1.61 1.51 1.54 1.54 105,410
Aug 25, 2026 1.61 1.64 1.55 1.59 1.59 142,438
Aug 24, 2026 1.60 1.65 1.51 1.58 1.58 83,105
Aug 21, 2026 1.63 1.66 1.50 1.58 1.58 212,508
Aug 20, 2026 1.71 1.72 1.59 1.61 1.61 133,879
Aug 19, 2026 1.72 1.75 1.65 1.72 1.72 196,454
Aug 18, 2026 1.83 1.93 1.68 1.70 1.70 282,117
Aug 17, 2026 2.03 2.03 1.75 1.80 1.80 367,791
Aug 14, 2026 1.83 2.08 1.74 1.80 1.80 470,549
Aug 13, 2026 1.58 2.08 1.54 1.87 1.87 2,292,957
Aug 12, 2026 2.33 2.40 1.63 1.67 1.67 1,147,013
Aug 11, 2026 3.20 3.37 2.29 2.31 2.31 600,781
Aug 10, 2026 4.07 4.15 3.50 3.66 3.66 72,953
Aug 7, 2026 4.35 4.35 3.96 4.02 4.02 70,017
Aug 6, 2026 4.49 4.70 4.02 4.41 4.41 78,957
Aug 5, 2026 4.84 5.06 4.39 4.54 4.54 54,586
Aug 4, 2026 5.14 5.28 4.61 4.72 4.72 85,578
Aug 3, 2026 5.13 5.50 5.06 5.15 5.15 84,506
Jul 31, 2026 5.00 5.17 4.92 5.02 5.02 14,712
Jul 30, 2026 5.02 5.60 4.85 4.96 4.96 62,501
Jul 29, 2026 4.90 5.06 4.90 4.98 4.98 66,737
Jul 28, 2026 4.69 4.88 4.65 4.83 4.83 26,823
Jul 27, 2026 5.21 5.30 4.60 4.69 4.69 137,382
Jul 24, 2026 4.98 5.25 4.80 4.89 4.89 108,793
Jul 23, 2026 4.96 5.09 4.60 4.67 4.67 67,942
Jul 22, 2026 5.33 5.50 4.72 4.94 4.94 256,077
Jul 21, 2026 4.59 5.11 4.49 4.75 4.75 50,467
Jul 20, 2026 4.68 4.68 4.46 4.52 4.52 15,867
Jul 17, 2026 4.90 4.90 4.50 4.63 4.63 25,360
Jul 16, 2026 4.70 5.10 4.37 4.98 4.98 70,030
Jul 15, 2026 4.81 4.81 4.36 4.73 4.73 46,906
Jul 14, 2026 4.89 5.10 4.46 4.65 4.65 73,296
Jul 13, 2026 4.91 5.13 4.52 4.75 4.75 89,889
Jul 10, 2026 4.96 5.08 4.46 4.96 4.96 61,526
Jul 9, 2026 5.28 5.28 4.94 4.96 4.96 37,742
Jul 8, 2026 5.11 5.36 4.64 4.93 4.93 102,354
Jul 7, 2026 5.90 5.90 4.97 5.29 5.29 206,466
Jul 6, 20261-for-20 reverse split 6.53 6.74 5.83 5.94 5.94 160,363
Jul 2, 2026 0.4400 0.4499 0.3405 0.3466 6.93 2,373,481
Jul 1, 2026 0.5199 0.5660 0.3886 0.4221 8.44 4,583,298
Jun 30, 2026 0.4460 0.5700 0.4107 0.5221 10.44 12,750,749
Jun 29, 2026 0.3219 0.4484 0.3140 0.4420 8.84 38,143,191
Jun 26, 2026 0.2120 0.3800 0.2060 0.3210 6.42 109,832,392
Jun 25, 2026 0.3640 0.3675 0.1806 0.2058 4.12 4,705,681
Jun 24, 2026 0.3740 0.3740 0.3368 0.3402 6.80 502,549
Jun 23, 2026 0.4100 0.4100 0.3600 0.3617 7.23 1,255,524
Jun 22, 2026 0.4200 0.4424 0.3885 0.4280 8.56 466,508
Jun 18, 2026 0.3800 0.4468 0.3800 0.4210 8.42 898,606
Jun 17, 2026 0.3800 0.5405 0.3800 0.4060 8.12 4,236,624
Jun 16, 2026 0.4206 0.4206 0.3784 0.3800 7.60 638,989
Jun 15, 2026 0.4400 0.4490 0.4151 0.4158 8.32 168,054
Jun 12, 2026 0.4150 0.4500 0.4150 0.4211 8.42 128,541
Jun 11, 2026 0.4379 0.4379 0.4116 0.4266 8.53 104,574
Jun 10, 2026 0.4400 0.4573 0.4202 0.4317 8.63 154,278
Jun 9, 2026 0.4840 0.4840 0.4421 0.4471 8.94 258,266
Jun 8, 2026 0.4740 0.4917 0.4601 0.4701 9.40 284,222
Jun 5, 2026 0.5087 0.5173 0.4700 0.4733 9.47 340,495
Jun 4, 2026 0.5020 0.5099 0.4969 0.5000 10.00 65,864
Jun 3, 2026 0.5136 0.5216 0.5000 0.5000 10.00 165,450
Jun 2, 2026 0.5176 0.5360 0.5001 0.5025 10.05 119,191
Jun 1, 2026 0.5500 0.5600 0.5130 0.5236 10.47 292,063
May 29, 2026 0.5330 0.5703 0.5005 0.5670 11.34 365,764
May 28, 2026 0.5100 0.5399 0.5100 0.5234 10.47 221,398
May 27, 2026 0.5100 0.5280 0.4874 0.5280 10.56 196,299
May 26, 2026 0.5180 0.5220 0.4941 0.4942 9.88 135,743
May 22, 2026 0.5040 0.5211 0.4880 0.5012 10.02 105,501
May 21, 2026 0.4987 0.5090 0.4784 0.4900 9.80 228,032
May 20, 2026 0.4826 0.5192 0.4709 0.4952 9.90 125,246
May 19, 2026 0.4721 0.4983 0.4700 0.4758 9.52 160,687
May 18, 2026 0.4995 0.5047 0.4637 0.4800 9.60 292,772
May 15, 2026 0.5000 0.5130 0.4902 0.4902 9.80 248,060
May 14, 2026 0.5001 0.5200 0.5001 0.5133 10.27 117,756
May 13, 2026 0.5300 0.5700 0.4901 0.5000 10.00 597,771
May 12, 2026 0.5500 0.5709 0.5391 0.5504 11.01 296,092
May 11, 2026 0.5600 0.5852 0.5502 0.5510 11.02 206,924
May 8, 2026 0.5866 0.5885 0.5523 0.5610 11.22 223,253
May 7, 2026 0.6165 0.6165 0.5750 0.5770 11.54 118,197
May 6, 2026 0.5700 0.6254 0.5700 0.6168 12.34 225,043
May 5, 2026 0.5840 0.6062 0.5643 0.5702 11.40 191,647
May 4, 2026 0.5700 0.6073 0.5620 0.5808 11.62 266,114
May 1, 2026 0.6161 0.6171 0.5909 0.5920 11.84 156,002
Apr 30, 2026 0.5613 0.6073 0.5502 0.6000 12.00 371,537
Apr 29, 2026 0.5606 0.5849 0.5300 0.5614 11.23 544,566
Apr 28, 2026 0.5900 0.5999 0.5694 0.5821 11.64 146,953
Apr 27, 2026 0.5824 0.6128 0.5689 0.5816 11.63 186,613
Apr 24, 2026 0.6075 0.6080 0.5500 0.5951 11.90 666,644
Apr 23, 2026 0.6020 0.6397 0.5814 0.6082 12.16 267,594
Apr 22, 2026 0.6200 0.6366 0.5811 0.6143 12.29 283,151
Apr 21, 2026 0.6390 0.6400 0.5718 0.5992 11.98 452,581
Apr 20, 2026 0.6100 0.6400 0.5853 0.6169 12.34 490,848
Apr 17, 2026 0.6178 0.6722 0.5831 0.6030 12.06 1,142,048
Apr 16, 2026 0.7130 0.7422 0.5900 0.5911 11.82 1,631,863
Apr 15, 2026 0.6124 0.7900 0.5970 0.6845 13.69 3,488,857
Apr 14, 2026 0.6291 0.6996 0.6174 0.6247 12.49 678,049
Apr 13, 2026 0.5000 0.6280 0.4902 0.6199 12.40 1,071,931
Apr 10, 2026 0.5100 0.5255 0.4971 0.4999 10.00 1,855,046
Apr 9, 2026 0.5700 0.5700 0.5060 0.5100 10.20 761,567
Apr 8, 2026 0.5800 0.5956 0.5404 0.5459 10.92 1,401,450
Apr 7, 2026 0.5430 0.5516 0.4903 0.5499 11.00 165,368
Apr 6, 2026 0.5583 0.5583 0.5213 0.5330 10.66 372,095
Apr 2, 2026 0.5500 0.5583 0.5200 0.5499 11.00 422,967
Apr 1, 2026 0.5500 0.5694 0.5300 0.5330 10.66 352,945
Mar 31, 2026 0.5500 0.5507 0.5083 0.5473 10.95 322,805
Mar 30, 2026 0.5555 0.6053 0.5001 0.5124 10.25 180,002
Mar 27, 2026 0.5836 0.6300 0.5230 0.5555 11.11 465,595
Mar 26, 2026 0.6730 0.7046 0.5750 0.5800 11.60 1,265,431
Mar 25, 2026 0.7100 0.7300 0.6800 0.7001 14.00 434,860
Mar 24, 2026 0.7390 0.7899 0.6705 0.7150 14.30 425,797
Mar 23, 2026 0.8000 0.8160 0.7330 0.7398 14.80 180,248
Mar 20, 2026 0.7625 0.8000 0.7500 0.7712 15.42 279,658
Mar 19, 2026 0.8130 0.8300 0.7500 0.7569 15.14 397,855
Mar 18, 2026 0.8883 0.8885 0.8106 0.8151 16.30 138,669
Mar 17, 2026 0.9023 0.9100 0.8650 0.8916 17.83 115,700
Mar 16, 2026 0.9680 0.9800 0.8500 0.8579 17.16 222,408
Mar 13, 2026 1.00 1.03 0.9200 0.9501 19.00 114,938
Mar 12, 2026 1.02 1.05 0.9906 1.01 20.20 61,646
Mar 11, 2026 1.01 1.05 1.01 1.01 20.20 50,889
Mar 10, 2026 1.03 1.09 1.00 1.01 20.20 96,009
Mar 9, 2026 1.02 1.09 0.9800 1.03 20.60 77,362
Mar 6, 2026 1.00 1.02 0.9900 0.9900 19.80 30,741
Mar 5, 2026 1.06 1.11 1.00 1.02 20.40 143,355
Mar 4, 2026 0.9899 1.05 0.9872 1.03 20.60 40,705
Mar 3, 2026 1.06 1.06 0.9500 0.9901 19.80 166,193
Mar 2, 2026 1.12 1.13 1.07 1.08 21.60 126,493
Feb 27, 2026 1.10 1.14 1.08 1.14 22.80 133,347
Feb 26, 2026 1.09 1.13 1.06 1.11 22.20 82,640
Feb 25, 2026 1.07 1.13 1.05 1.08 21.60 114,717
Feb 24, 2026 1.16 1.16 1.08 1.08 21.60 104,173
Feb 23, 2026 1.10 1.13 1.05 1.09 21.80 180,278
Feb 20, 2026 1.13 1.16 1.11 1.11 22.20 85,633
Feb 19, 2026 1.10 1.17 1.04 1.14 22.80 184,328
Feb 18, 2026 1.05 1.14 1.05 1.08 21.60 183,226
Feb 17, 2026 1.13 1.14 1.05 1.06 21.20 230,481
Feb 13, 2026 1.07 1.21 1.07 1.15 23.00 248,214
Feb 12, 2026 1.09 1.11 1.04 1.08 21.60 186,952
Feb 11, 2026 0.9800 1.10 0.9501 1.06 21.20 270,414
Feb 10, 2026 0.9900 1.06 0.9645 1.00 20.00 238,731
Feb 9, 2026 1.02 1.05 0.9528 0.9688 19.38 247,899
Feb 6, 2026 0.9400 1.05 0.9201 1.03 20.60 521,645
Feb 5, 2026 0.9500 1.02 0.9002 0.9106 18.21 147,749
Feb 4, 2026 0.9100 0.9871 0.8700 0.9500 19.00 404,397
Feb 3, 2026 0.8700 0.8899 0.8230 0.8710 17.42 242,751
Feb 2, 2026 0.8958 0.9200 0.8600 0.8720 17.44 138,972
Jan 30, 2026 0.9200 0.9286 0.8630 0.8980 17.96 149,550
Jan 29, 2026 0.9105 0.9400 0.8900 0.9107 18.21 113,564
Jan 28, 2026 0.9600 0.9605 0.9001 0.9160 18.32 334,614
Jan 27, 2026 0.9400 0.9646 0.9017 0.9500 19.00 129,109
Jan 26, 2026 0.9300 0.9500 0.8900 0.9200 18.40 181,829
Jan 23, 2026 0.9000 0.9800 0.8712 0.9394 18.79 262,966
Jan 22, 2026 0.9000 0.9547 0.8700 0.8994 17.99 296,729
Jan 21, 2026 0.9830 1.02 0.8800 0.8950 17.90 332,239
Jan 20, 2026 0.9800 1.04 0.9500 0.9680 19.36 289,251
Jan 16, 2026 0.9500 1.03 0.9100 0.9955 19.91 574,534
Jan 15, 2026 0.8800 0.9949 0.8800 0.9499 19.00 584,557
Jan 14, 2026 0.8900 0.9200 0.8420 0.9045 18.09 664,746
Jan 13, 2026 0.9190 0.9217 0.8713 0.8964 17.93 611,177
Jan 12, 2026 0.8500 0.9300 0.8060 0.9150 18.30 1,594,587
Jan 9, 2026 0.8700 0.8700 0.8030 0.8268 16.54 794,110
Jan 8, 2026 0.8600 0.9100 0.8200 0.8500 17.00 1,454,194
Jan 7, 2026 0.9129 0.9379 0.7710 0.8403 16.81 15,360,558
Jan 6, 2026 1.00 1.02 1.00 1.00 20.00 80,363
Jan 5, 2026 1.00 1.03 0.9847 0.9847 19.69 88,533
Jan 2, 2026 0.9800 1.02 0.9749 0.9830 19.66 114,850
Dec 31, 2025 1.01 1.06 0.9700 0.9871 19.74 166,934
Dec 30, 2025 1.05 1.07 0.9600 1.01 20.20 247,467
Dec 29, 2025 1.06 1.12 1.03 1.04 20.80 102,170
Dec 26, 2025 1.07 1.14 1.05 1.06 21.20 72,736
Dec 24, 2025 1.03 1.05 1.02 1.05 21.00 44,669
Dec 23, 2025 1.05 1.06 1.03 1.04 20.80 110,746
Dec 22, 2025 1.07 1.11 1.03 1.03 20.60 103,227
Dec 19, 2025 1.15 1.17 1.07 1.07 21.40 257,114
Dec 18, 2025 1.17 1.20 1.14 1.15 23.00 44,303
Dec 17, 2025 1.17 1.21 1.15 1.17 23.40 77,787
Dec 16, 2025 1.17 1.23 1.17 1.18 23.60 98,115
Dec 15, 2025 1.18 1.24 1.14 1.19 23.80 298,557
Dec 12, 2025 1.27 1.32 1.15 1.16 23.20 137,545
Dec 11, 2025 1.32 1.32 1.25 1.29 25.80 66,057
Dec 10, 2025 1.36 1.40 1.27 1.30 26.00 97,159
Dec 9, 2025 1.37 1.41 1.31 1.33 26.60 110,795
Dec 8, 2025 1.33 1.38 1.29 1.35 27.00 81,667
Dec 5, 2025 1.35 1.42 1.33 1.35 27.00 102,891
Dec 4, 2025 1.27 1.36 1.27 1.35 27.00 177,109
Dec 3, 2025 1.22 1.26 1.20 1.25 25.00 106,464
Dec 2, 2025 1.35 1.38 1.19 1.20 24.00 116,914
Dec 1, 2025 1.36 1.38 1.23 1.26 25.20 92,185
Nov 28, 2025 1.28 1.38 1.26 1.37 27.40 118,527
Nov 26, 2025 1.14 1.29 1.10 1.25 25.00 171,899
Nov 25, 2025 1.14 1.20 1.08 1.13 22.60 64,671
Nov 24, 2025 1.18 1.21 1.12 1.13 22.60 57,987
Nov 21, 2025 1.13 1.20 1.09 1.17 23.40 78,148
Nov 20, 2025 1.14 1.21 1.08 1.08 21.60 138,362
Nov 19, 2025 1.25 1.25 1.06 1.13 22.60 135,904
Nov 18, 2025 1.26 1.32 1.20 1.23 24.60 92,185
Nov 17, 2025 1.30 1.35 1.22 1.23 24.60 239,519
Nov 14, 2025 1.14 1.35 1.14 1.33 26.60 130,006
Nov 13, 2025 1.22 1.26 1.13 1.13 22.60 81,432
Nov 12, 2025 1.27 1.35 1.18 1.23 24.60 75,201
Nov 11, 2025 1.30 1.31 1.24 1.25 25.00 39,489
Nov 10, 2025 1.31 1.35 1.30 1.31 26.20 38,568
Nov 7, 2025 1.35 1.39 1.21 1.31 26.20 233,916
Nov 6, 2025 1.43 1.49 1.40 1.46 29.20 73,624
Nov 5, 2025 1.49 1.49 1.42 1.42 28.40 61,058
Nov 4, 2025 1.46 1.48 1.43 1.46 29.20 48,965
Nov 3, 2025 1.59 1.59 1.46 1.48 29.60 74,978
Oct 31, 2025 1.49 1.52 1.48 1.49 29.80 46,487
Oct 30, 2025 1.48 1.51 1.46 1.49 29.80 49,383
Oct 29, 2025 1.49 1.52 1.47 1.50 30.00 43,895
Oct 28, 2025 1.54 1.55 1.48 1.50 30.00 76,755
Oct 27, 2025 1.61 1.65 1.54 1.56 31.20 204,732
Oct 24, 2025 1.66 1.68 1.58 1.61 32.20 121,663
Oct 23, 2025 1.53 1.63 1.48 1.63 32.60 66,262
Oct 22, 2025 1.63 1.63 1.49 1.53 30.60 53,011
Oct 21, 2025 1.61 1.61 1.54 1.58 31.60 48,299
Oct 20, 2025 1.56 1.61 1.55 1.58 31.60 67,246
Oct 17, 2025 1.55 1.57 1.52 1.54 30.80 40,490
Oct 16, 2025 1.54 1.60 1.52 1.56 31.20 50,176
Oct 15, 2025 1.56 1.63 1.47 1.52 30.40 82,621
Oct 14, 2025 1.48 1.55 1.46 1.54 30.80 96,393
Oct 13, 2025 1.59 1.62 1.43 1.45 29.00 77,538
Oct 10, 2025 1.62 1.67 1.52 1.52 30.40 110,922
Oct 9, 2025 1.67 1.68 1.60 1.61 32.20 64,601
Oct 8, 2025 1.63 1.68 1.61 1.62 32.40 98,222
Oct 7, 2025 1.65 1.70 1.60 1.62 32.40 45,733
Oct 6, 2025 1.70 1.72 1.61 1.66 33.20 76,753
Oct 3, 2025 1.63 1.74 1.61 1.65 33.00 109,532
Oct 2, 2025 1.67 1.68 1.61 1.61 32.20 36,063
Oct 1, 2025 1.64 1.69 1.64 1.67 33.40 27,374
Sep 30, 2025 1.66 1.71 1.59 1.66 33.20 40,210
Sep 29, 2025 1.71 1.74 1.58 1.66 33.20 131,110
Sep 26, 2025 1.70 1.73 1.64 1.69 33.80 82,509
Sep 25, 2025 1.70 1.70 1.64 1.64 32.80 85,623

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Curis Inc Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at CRIS, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation